A detailed history of Jane Street Group, LLC transactions in Immunity Bio, Inc. stock. As of the latest transaction made, Jane Street Group, LLC holds 95,609 shares of IBRX stock, worth $250,495. This represents 0.0% of its overall portfolio holdings.

Number of Shares
95,609
Previous 1,716,059 94.43%
Holding current value
$250,495
Previous $10.8 Million 96.74%
% of portfolio
0.0%
Previous 0.01%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$3.32 - $6.7 $5.38 Million - $10.9 Million
-1,620,450 Reduced 94.43%
95,609 $354,000
Q2 2024

Aug 14, 2024

BUY
$4.82 - $9.15 $6.79 Million - $12.9 Million
1,407,921 Added 456.91%
1,716,059 $10.8 Million
Q1 2024

May 15, 2024

SELL
$3.23 - $6.17 $1.66 Million - $3.17 Million
-513,505 Reduced 62.5%
308,138 $1.65 Million
Q4 2023

Feb 14, 2024

BUY
$1.25 - $5.21 $1.03 Million - $4.28 Million
821,643 New
821,643 $4.12 Million
Q2 2023

Aug 14, 2023

SELL
$1.53 - $6.41 $119,376 - $500,133
-78,024 Reduced 34.71%
146,732 $407,000
Q1 2023

May 15, 2023

BUY
$1.35 - $4.78 $240,159 - $850,342
177,896 Added 379.63%
224,756 $409,000
Q4 2022

Feb 14, 2023

BUY
$4.35 - $6.77 $121,739 - $189,465
27,986 Added 148.28%
46,860 $237,000
Q3 2022

Nov 14, 2022

SELL
$3.65 - $6.43 $86,618 - $152,590
-23,731 Reduced 55.7%
18,874 $94,000
Q2 2022

Aug 16, 2022

SELL
$2.68 - $6.14 $286,762 - $656,986
-107,001 Reduced 71.52%
42,605 $159,000
Q1 2022

May 17, 2022

BUY
$5.05 - $7.53 $618,135 - $921,694
122,403 Added 449.96%
149,606 $840,000
Q4 2021

Feb 15, 2022

BUY
$5.67 - $10.18 $85,872 - $154,176
15,145 Added 125.6%
27,203 $165,000
Q3 2021

Nov 16, 2021

SELL
$9.17 - $14.24 $164,968 - $256,177
-17,990 Reduced 59.87%
12,058 $118,000
Q2 2021

Aug 16, 2021

SELL
$13.41 - $22.4 $168,000 - $280,627
-12,528 Reduced 29.43%
30,048 $429,000
Q1 2021

May 18, 2021

BUY
$12.83 - $42.25 $546,250 - $1.8 Million
42,576 New
42,576 $1.01 Million

Others Institutions Holding IBRX

About ImmunityBio, Inc.


  • Ticker IBRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 400,304,000
  • Market Cap $1.05B
  • Description
  • ImmunityBio, Inc., a clinical-stage biotechnology company, develops therapies and vaccines to treat cancers and infectious diseases. It offers immunotherapy and cell therapy platforms, including antibody cytokine fusion proteins, synthetic immunomodulators, vaccine technologies, natural killer cells, and adaptive (T cell) immune systems. The com...
More about IBRX
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.